Shionogi & Co. reports FY results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 14 2024
0mins
Source: SeekingAlpha
- Shionogi & Co. FY Revenue: Revenue for Shionogi & Co. increased by 2.0 percent to 435.1 billion yen.
- FY EPS: Shionogi & Co. reported earnings per share (EPS) of 621.10 yen.
- ViiV's HIV Therapy: ViiV's long-acting HIV therapy showed better results than daily therapy in a Phase 3 trial.
- Seeking Alpha's Quant Rating: Seeking Alpha provided a Quant Rating on Shionogi & Co.
- Historical and Financial Data: Information on historical earnings and financial data for Shionogi & Co. was available.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
